Amylyx Pharmaceuticals (AMLX) R&D In Process (2024)
Amylyx Pharmaceuticals (AMLX) has 1 years of R&D In Process data on record, last reported at $36.2 million in Q3 2024.
Amylyx Pharmaceuticals (AMLX) has 1 years of R&D In Process data on record, last reported at $36.2 million in Q3 2024.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month